Biomedical, Clinical & Life Sciences

NIH RFA-NS-24-014: 2023 Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)

No Applicants // Limit: 1 // Tickets Available: 1 

 

The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

The fully integrated educational activities should prepare undergraduate students from diverse backgrounds, including those from groups underrepresented in biomedical and behavioral sciences, to enter Ph.D. degree programs in the neurosciences. To accomplish this goal, this initiative will provide institutional awards to develop neuroscience research education programs comprised of collaborative partnerships integrated across different educational institution types.

Funding Type
Internal Deadline
External Deadline
02/15/2024

HRSA HRSA-24-039 & HRSA-24-040: 2023 Maternal and Child (MCH) Health – Improving Oral Health Integration

No applicants  // Limit: 1 // Tickets Available: 1 

 

The program’s purpose is to integrate preventive oral health care into primary care services accessible to MCH populations living in communities underserved by oral health care. The MCH-IOHI Program consists of two types of projects:

  • HRSA-24-039: MCH-IOHI Demonstration Projects will aim to improve access to integrated preventive oral health care (integrated POHC) in primary care services accessible to MCH populations at increased or higher risk for poor oral health. 
     
  • HRSA-24-040: MCH-IOHI Consortium will bridge the gap between evidence and practice. As the principal technical assistance (TA) provider, the Consortium will accelerate the adoption and implementation of evidence-based integrated POHC strategies that aim to advance health equity.
Funding Type
Internal Deadline
External Deadline
01/22/2024

NIH 2024 S10 Instrumentation Programs: Shared Instrumentation Grant Program (SIG) & High-End Instrumentation Grant Program (HEI)

Institutionally coordinated

 

ORIP's S10 Instrumentation Grant Programs support purchases of state-of-the-art commercially available instruments to enhance research of NIH-funded investigators. Instruments that are awarded are typically too expensive to be obtained by an individual investigator with a research project grant. Every instrument awarded by an S10 grant is to be used on a shared basis, which makes the programs cost-efficient and beneficial to thousands of investigators in hundreds of institutions nationwide.

To be eligible for an S10 award, an institution must identify three or more principal investigators with active NIH research awards who demonstrate a substantial need for the requested instrument. Matching funds are not required. Types of instruments supported by S10 funding include, but are not limited to, X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-analyzers, and biomedical imagers.

Active RFPs are: 

There is no restriction on the number of applications an institution can submit to the SIG and/or High-End HEI Grant Programs. However, institutional internal coordination is required for concurrent SIG or HEI applications to verify each proposal is requesting different types of equipment.

Solicitation 

Internal Deadline
External Deadline
06/03/2024

HRSA HRSA-24-015: 2024 Nurse Faculty Loan Program (NFLP)

No Applicants  // Limit: 1 // Tickets Available: 1 

 

The NFLP program seeks to increase the number of qualified nursing faculty nationwide by providing low interest loans for individuals studying to be nurse faculty and loan cancelation for those who then go on to work as faculty.  Successful applicants establish and operate a student loan program including maintaining a fund, providing loans to students enrolled in advanced education nursing degree programs, and monitoring compliance with program requirements. In exchange for completion of up to four years of post-graduation full-time nurse faculty employment in an accredited school of nursing, graduates receive cancellation of up to 85 percent of the original student loan amount (plus interest thereon) as authorized by the program. Advance Practice Registered Nurses (APRNs) who serve as full-time preceptors within an academic-practice partnership framework are considered faculty under the NFLP, to support the expansion of clinical training opportunities for nursing students.

Solicitation

Funding Type
Internal Deadline
External Deadline
02/15/2024

NIH PAR-23-306: 2024 Biomedical Research Facilities (C06 Clinical Trial Not Allowed)

Institutionally Coordinated // Limit: 1 // M. Dake ( University of Arizona Health Sciences)

 

Moreover, institutions with C06 awards funded under the Biomedical Research Facility Program (NOFOs PAR-21-139PAR-22-088 or PAR-23-045) are not eligible to apply to this NOFO, provided the awards are active on the receipt date for this NOFO. Thus, only one C06 Biomedical Research Facility active award per institution would be allowed at any given time.

This Notice of Funding Opportunity (NOFO) invites applications from eligible academic and research institutions to apply for funding to modernize existing or construct new biomedical research facilities. Applications will be accepted from public and private nonprofit institutions of higher education as well as from non-profit research organizations. Applications from both research-intensive institutions and Institutions of Emerging Excellence (IEE) in biomedical research, both highly resourced and low-resourced institutions, from all geographic regions in the nation are strongly encouraged.

NIH recognizes the importance of all institutions of higher learning in contributing to the nation’s research capacity. The goal of this NOFO is to modernize biomedical research infrastructure to strengthen biomedical research programs. Each project is expected to provide long-term improvements to the institutional research infrastructure. Intended projects are the construction or modernization of core facilities and the development of other shared research infrastructure serving an institution-wide research community with broad impact on biomedical research.

Internal Deadline
External Deadline
01/25/2024

RARE Grant Program (Research Accelerating RUNX1 Exploration) Early Career Investigator Grant and Exploration Grant

The purpose of the RUNX1 Early Career Investigator Grant is to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.
Opportunity ID
5edd8ba9-5d10-4c4d-979b-d1d75de8f0f3
External Deadline
12/03/2023

Early Career Investigator Grant

Ovarian Cancer Research Alliance is requesting Letters of Intent for the Early Career Investigator Grant (formerly called the Liz Tilberis Early Career Award). The Early Career Investigator Grant (ECIG) is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent of these grants is to support a substantial time commitment to research and academic endeavors in ovarian cancer.
Opportunity ID
6c66cfe8-729a-4c83-8e5b-d1d75de8f0f3
External Deadline
03/29/2024 (Anticipated)

NIDCD Early Career Research (ECR) Award

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

Only one NIDCD ECR Award (R21) application may be submitted by a PD/PI per due date. PD/PIs who successfully obtained an NIDCD Small Grant award are ineligible for an NIDCD ECR Award (R21).

Applicants may not submit an NIDCD R01, R15 or R21 application for the same review cycle that the NIDCD ECR Award application is submitted. In such cases, the NIDCD ECR Award R21 application will be withdrawn.

External Deadline
02/27/2024

NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional)

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

Only one NIDCD ECR Award (R21) application may be submitted by a PD/PI per due date. PD/PIs who successfully obtained an NIDCD Small Grant award are ineligible for an NIDCD ECR Award (R21).

Applicants may not submit an NIDCD R01, R15 or R21 application for the same review cycle that the NIDCD ECR Award application is submitted. In such cases, the NIDCD ECR Award R21 application will be withdrawn.
External Deadline
01/27/2024

Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)

This Funding Opportunity Announcement is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing innovative research in genomics. This opportunity is open to research in all areas relevant to the mission of NHGRI, including genomic sciences, genomic medicine, genomic data science, and ethical, legal, and social implications of genomics.

The PD/PI must be an NIH defined Early Stage Investigator, and this eligibility must be included in the NIH Commons record prior to the review of the application.

In addition, the PD/PI must be an independent researcher with a faculty appointment that is tenure track or equivalent (generally at the level of Assistant Professor or Research Assistant Professor), and have dedicated, independent laboratory space or access to the research resources which will allow them to conduct the research proposed in the grant application as the lead PD/PI
External Deadline
01/27/2024

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now